StockData
Imunon, Inc. logo

Imunon, Inc. (IMNN) income statement

IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.98−0.04 (-3.43%)

Close on Oct 19, 2026Market cap $4.95MP/E –Yield –

See a number that looks wrong?